THC Biomed Intl Ltd. (THCBF)
USD 0.0
(-95.92%)
USD 0.0
(-95.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -1.85 Million | -1.01 Million | 114.93 Thousand | -1.86 Million | -2.43 Million |
| Net Income | - | -3.06 Million | -6.35 Million | -161.59 Thousand | -12.69 Million | -12.45 Million |
| Depreciation & Amortization | - | 928.53 Thousand | 979.95 Thousand | 1.01 Million | 604.69 Thousand | 198.41 Thousand |
| Deferred income taxes | - | -455.38 Thousand | - | - | 2672.00 | 2.22 Million |
| Stock-based compensation | - | 137.44 Thousand | 671.01 Thousand | 698.49 Thousand | 3.9 Million | 1.14 Million |
| Change in working capital | - | -460.26 Thousand | 750.27 Thousand | 675.13 Thousand | 1525.00 | -825.5 Thousand |
| Other non-cash items | - | 1.05 Million | 2.94 Million | -2.11 Million | 6.32 Million | 7.28 Million |
| Investing Cash Flow | - | 2.48 Million | -396.92 Thousand | -1.51 Million | -7.14 Million | -5.06 Million |
| Investments in PPE | - | -160.3 Thousand | -369.31 Thousand | -1.42 Million | -7.15 Million | -5.13 Million |
| Acquisitions | - | 2.64 Million | - | - | 6524.00 | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 2.64 Million | -27.61 Thousand | -83.14 Thousand | 6524.00 | 70.74 Thousand |
| Financing Cash Flow | - | -250.28 Thousand | 766.87 Thousand | 1.15 Million | 7.99 Million | 9.47 Million |
| Debt repayment | - | -2.05 Million | -226.87 Thousand | -563.37 Thousand | -99 Thousand | -135 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -163.44 Thousand | - | - |
| Common Stock Issuance | - | 15 Thousand | 573.37 Thousand | 216.34 Thousand | 6.1 Million | 9.65 Million |
| Other Financing Activities | - | 1.78 Million | 420.37 Thousand | 3.24 Million | 1.98 Million | -46.74 Thousand |
| Accounts receivables | - | 106.78 Thousand | -328.04 Thousand | - | - | - |
| Accounts payables | - | 228.26 Thousand | 519.29 Thousand | - | - | - |
| Inventory | - | -610.52 Thousand | 1.57 Million | - | - | - |
| Other working capital | - | -184.78 Thousand | -1.01 Million | 675.13 Thousand | 1525.00 | -717.91 Thousand |
| Cash at beginning of period | 484.08 Thousand | 111.16 Thousand | 751.45 Thousand | 991.15 Thousand | 2 Million | 22.85 Thousand |
| Cash at end of period | 484.08 Thousand | 484.08 Thousand | 111.16 Thousand | 751.45 Thousand | 991.15 Thousand | 2 Million |
| Capital Expenditure | - | -160.3 Thousand | -369.31 Thousand | -1.42 Million | -7.15 Million | -5.13 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 372.92 Thousand | -640.29 Thousand | -239.69 Thousand | -1.01 Million | 1.98 Million |
| Free Cash Flow | - | -2.01 Million | -1.37 Million | -1.31 Million | -9.02 Million | -7.56 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | -935.21 Thousand | -992.01 Thousand | -331.47 Thousand |
| Depreciation & Amortization | - | - | - | 191.92 Thousand | 213.25 Thousand | 212.22 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 659.68 Thousand | 423.45 Thousand | -218.11 Thousand |
| Other non-cash items | - | - | - | 122.51 Thousand | 317.97 Thousand | 104.02 Thousand |
| Investing Cash Flow | - | - | - | -80.12 Thousand | -131.81 Thousand | 23.04 Thousand |
| Investments in PPE | - | - | - | -352.00 | -71.13 Thousand | -352.00 |
| Acquisitions | - | - | - | - | -64 Thousand | - |
| Investment purchases | - | - | - | - | -64 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | 64 Thousand | - |
| Other Investing Activities | - | - | - | -79.76 Thousand | 3324.00 | 23.39 Thousand |
| Financing Cash Flow | - | - | - | 151.84 Thousand | 95.35 Thousand | -105.62 Thousand |
| Debt repayment | - | - | - | -96.2 Thousand | -105.9 Thousand | -105.62 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 248.05 Thousand | 201.25 Thousand | -105.62 Thousand |
| Accounts receivables | - | - | - | 338.14 Thousand | -240.33 Thousand | 163.7 Thousand |
| Accounts payables | - | - | - | 238.12 Thousand | 580.46 Thousand | -50.05 Thousand |
| Inventory | - | - | - | 375.8 Thousand | 47.13 Thousand | -467.93 Thousand |
| Other working capital | - | - | - | -292.38 Thousand | 36.19 Thousand | 136.17 Thousand |
| Cash at beginning of period | - | 484.08 Thousand | 205.01 Thousand | 94.37 Thousand | 168.17 Thousand | 484.08 Thousand |
| Cash at end of period | - | 484.08 Thousand | 205.01 Thousand | 205.01 Thousand | 94.37 Thousand | 168.17 Thousand |
| Capital Expenditure | - | - | - | -352.00 | -71.13 Thousand | -352.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | 110.63 Thousand | -73.79 Thousand | -315.91 Thousand |
| Free Cash Flow | - | - | - | 38.55 Thousand | -108.47 Thousand | -233.68 Thousand |
FHLD
UTLH
AGIO
300886
3172
ABIT